NASDAQ$BTSG

Brightspring Health Services Inc · Q3 2025 earnings

Q3 2025 earnings ·

Briefing

BrightSpring Health Services reported Q3 2025, revenue of $3.33B, net income of $55.8M, diluted EPS of $0.19.

For Q3 2025, BrightSpring Health Services reported revenue of $3.33B, net income of $55.8M, diluted EPS was $0.19. The filing discusses segment trends, liquidity, and management outlook for upcoming periods.

  • Revenue $3.33B.
  • Net income $55.8M.
  • Diluted EPS $0.19.

Headline financials

Total Revenue

$3.33B

Previous: $2.91B+14.7%
EPS (adj)

$0.19

Previous: -$0.04+575.0%
Capital Expenditures

-$57.8M

Previous: -$65.6M+11.9%
Free Cash Flow

-$1.98M

Previous: -$73.8M+97.3%
Net Income

$55.8M

Previous: -$8.23M+778.4%
Operating Income

$87.8M

Previous: $56.8M+54.5%
Gross Profit

$392M

Previous: $408M-3.9%
Cash & Equivalents

$140M

Previous: $36M+290.1%
Total Assets

$6.05B

Previous: $5.79B+4.6%

Revenue & EPS history

Brightspring Health Services Inc · Revenue · Quarterly

$3.33B

Q3 2025+14.7%vs Q3 2024
Beat estimate in 2 of 2 quarters(100%)
ActualEstimate

Forward guidance

The release discusses BrightSpring Health Services's outlook, capital allocation, and key risks for upcoming quarters, including guidance ranges or operating priorities where disclosed.

Tailwinds

  • BrightSpring Health Services cites demand and execution supporting the near-term outlook.
  • Liquidity and balance-sheet capacity support operations and shareholder returns.

Headwinds

  • Macro, input costs, and FX may pressure margins quarter to quarter.
  • Segment mix and one-time items can affect comparability versus prior periods.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 8 quarterly earnings reports · overlaid with Q3 2025

Historical avgQ3 2025

+4.4%

Avg return

Earnings day

+7.8%

Avg return

5 days after

+15.8%

Avg return

30 days after

75%

6 / 8 earnings

Positive

+16.6%

Q1 2025

Best reaction

-8.7%

Q2 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+9.6%+9.9%+28.5%
Q4 2025+3.2%+4.6%+5.5%
Q3 2025+0.5%-2.3%+7.8%
Q2 2025-4.9%-0.7%+14.7%
Q1 2025+16.6%+28.7%+33.0%
Q3 2024+15.2%+22.6%+28.9%
Q2 2024-8.7%-8.1%+2.6%
Q1 2024+3.8%+7.7%+5.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro